Bladder cancer immunotherapy by BCG Is associated with a significantly reduced risk of Alzheimer’s disease and Parkinson’s disease

Danielle Klinger, Brian L. Hill, Noam Barda, Eran Halperin, Ofer N. Gofrit, Charles L. Greenblatt, Nadav Rappoport, Michal Linial*, Hervé Bercovier

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

49 Scopus citations

Fingerprint

Dive into the research topics of 'Bladder cancer immunotherapy by BCG Is associated with a significantly reduced risk of Alzheimer’s disease and Parkinson’s disease'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience